130 related articles for article (PubMed ID: 11278043)
1. Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and orally active prodrugs.
Patrick DA; Hall JE; Bender BC; McCurdy DR; Wilson WD; Tanious FA; Saha S; Tidwell RR
Eur J Med Chem; 1999; 34(7-8):575-83. PubMed ID: 11278043
[TBL] [Abstract][Full Text] [Related]
2. Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.
Hall JE; Kerrigan JE; Ramachandran K; Bender BC; Stanko JP; Jones SK; Patrick DA; Tidwell RR
Antimicrob Agents Chemother; 1998 Mar; 42(3):666-74. PubMed ID: 9517949
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP).
Balkovec JM; Black RM; Hammond ML; Heck JV; Zambias RA; Abruzzo G; Bartizal K; Kropp H; Trainor C; Schwartz RE
J Med Chem; 1992 Jan; 35(1):194-8. PubMed ID: 1732529
[No Abstract] [Full Text] [Related]
4. Prodrugs for amidines: synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-bis(4-amidinophenyl)furan.
Rahmathullah SM; Hall JE; Bender BC; McCurdy DR; Tidwell RR; Boykin DW
J Med Chem; 1999 Sep; 42(19):3994-4000. PubMed ID: 10508447
[TBL] [Abstract][Full Text] [Related]
5. 2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents.
Francesconi I; Wilson WD; Tanious FA; Hall JE; Bender BC; Tidwell RR; McCurdy D; Boykin DW
J Med Chem; 1999 Jun; 42(12):2260-5. PubMed ID: 10377232
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of an endo/exonuclease in Pneumocystis carinii that is inhibited by dicationic diarylfurans with efficacy against Pneumocystis pneumonia.
Hildebrandt E; Boykin DW; Kumar A; Tidwell RR; Dykstra CC
J Eukaryot Microbiol; 1998; 45(1):112-21. PubMed ID: 9495040
[TBL] [Abstract][Full Text] [Related]
7. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
Tidwell RR; Jones SK; Geratz JD; Ohemeng KA; Cory M; Hall JE
J Med Chem; 1990 Apr; 33(4):1252-7. PubMed ID: 2319567
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.
Cushion MT; Walzer PD; Ashbaugh A; Rebholz S; Brubaker R; Vanden Eynde JJ; Mayence A; Huang TL
Antimicrob Agents Chemother; 2006 Jul; 50(7):2337-43. PubMed ID: 16801410
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
[TBL] [Abstract][Full Text] [Related]
10. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
Jones SK; Hall JE; Allen MA; Morrison SD; Ohemeng KA; Reddy VV; Geratz JD; Tidwell RR
Antimicrob Agents Chemother; 1990 Jun; 34(6):1026-30. PubMed ID: 2393262
[TBL] [Abstract][Full Text] [Related]
11. Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia.
Tidwell RR; Jones SK; Naiman NA; Berger LC; Brake WB; Dykstra CC; Hall JE
Antimicrob Agents Chemother; 1993 Aug; 37(8):1713-6. PubMed ID: 8215291
[TBL] [Abstract][Full Text] [Related]
12. Extended aromatic furan amidino derivatives as anti-Pneumocystis carinii agents.
Hopkins KT; Wilson WD; Bender BC; McCurdy DR; Hall JE; Tidwell RR; Kumar A; Bajic M; Boykin DW
J Med Chem; 1998 Sep; 41(20):3872-8. PubMed ID: 9748362
[TBL] [Abstract][Full Text] [Related]
13. Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics.
Maciejewska D; Zabinski J; Kaźmierczak P; Rezler M; Krassowska-Świebocka B; Collins MS; Cushion MT
Eur J Med Chem; 2012 Feb; 48():164-73. PubMed ID: 22200403
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental Pneumocystis carinii pneumonia with 1,3-di(4-imidazolino-2-methoxyphenoxy)propane lactate.
Tidwell RR; Jones SK; Dykstra CC; Gorton L; Hall JE
J Protozool; 1991; 38(6):148S-150S. PubMed ID: 1818146
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental Pneumocystis carinii pneumonia with analogs of pentamidine.
Tidwell RR; Kilgore SG; Ohemeng KA; Geratz JD; Hall JE
J Protozool; 1989; 36(1):74S-76S. PubMed ID: 2785206
[TBL] [Abstract][Full Text] [Related]
16. Dicationic diarylfurans as anti-Pneumocystis carinii agents.
Boykin DW; Kumar A; Spychala J; Zhou M; Lombardy RJ; Wilson WD; Dykstra CC; Jones SK; Hall JE; Tidwell RR
J Med Chem; 1995 Mar; 38(6):912-6. PubMed ID: 7699707
[TBL] [Abstract][Full Text] [Related]
17. Antipneumocystis activity of 17C91, a prodrug of atovaquone.
Comley JC; Yeates CL; Frend TJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2217-9. PubMed ID: 8619570
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
19. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
González-García J; Rubio García R; Antela López A; García Alcaide F
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
[TBL] [Abstract][Full Text] [Related]
20. Pentamidine congeners. 2. 2-butene-bridged aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii pneumonia agents.
Donkor IO; Tidwell RR; Jones SK
J Med Chem; 1994 Dec; 37(26):4554-7. PubMed ID: 7799405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
